Skip to content

Evaluation of Male and Female External Catheters for Urine Output Monitoring in the ICU

A Prospective, Observational Pilot Study Evaluating the Performance and Clinical Acceptance of PureWick® When Used in the ICU for Urine Output Monitoring

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07744945
Enrollment
32
Registered
2026-08-04
Start date
2026-08-01
Completion date
2026-10-01
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Patients, Urine Output

Brief summary

The goal of this observational pilot study is to learn about the ability of the PureWick® Flex Female External Catheter and the PureWIck® Male External Catheter to capture urine output in adult ICU patients compared to indwelling urinary catheters. The study will also gather feedback from ICU clinicians about the suitability of PureWick® urine output data to inform clinical decision-making.

Interventions

A thin, flexible, sterile tube that is inserted through the urethra into the bladder to drain urine, typically into a urine meter

DEVICEExternal Urinary Catheter

A non-sterile, external catheter intended for non-invasive urine output management

Sponsors

C. R. Bard
Lead SponsorINDUSTRY
Becton, Dickinson and Company
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients =18 years at the time of ICU admission 2. Female and Male Patients requiring urine output monitoring 3. Provision of a signed and dated informed consent form

Exclusion criteria

1. Frequent episodes of bowel incontinence without a fecal management system in place; or 2. Has moderate to heavy menstruation or vaginal bleeding and cannot use a tampon or menstrual cup; or 3. Has urinary retention; or 4. Is agitated, combative, restless, and/or uncooperative and may remove or dislodge the external catheter or indwelling catheter; or 5. Presence of moderate to severe insensible fluid loss, including but not limited to: Diaphoresis; Anasarca; or, based on the investigator's assessment, is unlikely to provide accurate urine leakage measurements on the pad due to the presence of other fluids (e.g. blood, stool); or 6. Any other condition that, in the opinion of the investigator, would preclude them from participating in the study

Design outcomes

Primary

MeasureTime frameDescription
Urine Capture RateApproximately every 4 hours for up to 72 hoursCapture rate is calculated as the weight of captured urine (post-void graduated cylinder weight - pre-void graduated cylinder weight) / total urine volume (captured urine + leaked urine (post-void absorbent pad weight - pre-void absorbent pad weight) \* 100

Secondary

MeasureTime frameDescription
ICU Clinician AcceptabilityFrom start of the observation period to the end of the observation period, up to 72 hoursA survey completed by ICU clinicians to assess the suitability of using urine output measurement data to inform clinical decision making on a 4-point Likert scale with lower scores indicating a better outcome.

Countries

United States

Contacts

CONTACTJosh Hobson
joshua.hobson@bd.com484-790-4982
CONTACTKirsten Hammitt
Kirsten.Hammitt@bd.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026